Available Until 12/13/2022

Clinical Sessions for Recertification: Geriatric Pharmacy (Cert # L219362)

ACPE Numbers: Various – see listing below
Pre-Sale Date: N/A
Content Release Date: 12/15/2021
Expiration Date: 12/13/2022
Activity Type: Application-based
CE Credits: 5.0 (BPS and ACPE) contact hours
Activity Fee: $150 (ASHP member); $250 (non-member)

Activity Overview

The Clinical Sessions Package is intended for board certified pharmacists in need of recertification credit and is designed based on the content outline developed by the Board of Pharmacy Specialties (BPS). Using a case-based approach, the activities provide high-level, interactive discussions on contemporary and emerging issues in geriatric pharmacy. 

The Geriatric Pharmacy Clinical Sessions Recertification Package consists of 4 activities (see table below) and provides up to 5.0 contact hours of continuing pharmacy education and/or recertification credit.   

These activities are part of the ASHP and ACCP professional development program for BCGP recertification approved by the BPS.  For pharmacists who maintain more than one certification, three of the activities are approved for multiple specialties (see table below). 

The American Society of Health-System Pharmacists and the American College of Clinical Pharmacy are accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

These recertification activities are intended for board certified pharmacists seeking to update their knowledge and skills in:

  • Geriatrics
  • STIs
  • Direct Oral Anticoagulant Dilemmas
  • Ageism
  • CKD

Board certified pharmacists are eligible to receive up to 5.0 contact hours of recertification credit for completing this package. To earn recertification credit, learners must review the activity content and successfully complete the online assessments by the deadline. Only completed assessments will be eligible for credit; no partial or incomplete assessments will be processed. You are allowed only one attempt to successfully complete this assessment. 

Recertification credit is earned in the calendar year in which you pass the recertification assessment.

Learning Activity

ACPE Number

Contact Hours (ACPE & BPS)

Recertification Assessment

Updates on the Management of Sexually Transmitted Infections in Older Adult Patients (BCACP)

0204-9999-21-288-H01-P

1.00

75%

Impact of Ageism on Therapeutic Outcomes and Patient-Provider Relationships (BCACP, BCGP)

0204-9999-21-237-H04-P

1.00

75%

Direct Oral Anticoagulant Dilemmas: Stroke Prevention for Atrial Fibrillation in the Oldest Old and Patients with End-Stage Renal Disease (BCACP, BCGP)

0204-9999-21-321-H01-P 1.50

73%

Infiltrating the Kidneys: Non-Dialysis CKD in Primary Care (BCACP, BCGP)

0217-9999-21-155-H01-P

1.50

71%

Updates on the Management of Sexually Transmitted Infections in Older Adult Patients:
ACPE number 0204-9999-21-288-H01-P

At the conclusion of this application-based educational activity, participants should be able to do the following:

  • Describe recent rates of diagnosis and trends of sexually transmitted infections (STIs) in older adult patients.
  • Apply current evidence and new CDC guidelines to the management of STIs in older patients.
  • Recommend strategies to help optimize sexual health services that include information on STIs in older adult patients.

This activity is approved for Board Certified Geriatric Pharmacist (BCACP) recertification credit. 

Impact of Ageism on Therapeutic Outcomes and Patient-Provider Relationships
ACPE Number: 0204-9999-21-237-H04-P

At the conclusion of this application-based educational activity, participants should be able to do the following:

  • Assess personal communication techniques with older adults for unintended ageist tendencies.
  • Recommend practices to combat areas of known ageism in institutional and ambulatory healthcare settings.
  • Develop a personalized action plan for recognizing personal and systematic ageist tendencies in healthcare.

This activity is approved for Board Certified Ambulatory Care Pharmacist (BCACP) and Board Certified Geriatric Pharmacist (BCGP) recertification credit. 

Direct Oral Anticoagulant Dilemmas: Stroke Prevention for Atrial Fibrillation in the Oldest Old and Patients with End-Stage Renal Disease
ACPE Number: 0204-9999-21-321-H01-P

At the conclusion of this application-based educational activity, participants should be able to do the following:

  • Assess stroke risk and the net clinical benefit of anticoagulation in the oldest old (i.e., patients age ≥80 years) with atrial fibrillation.
  • Assess stroke risk and the net clinical benefit of anticoagulation in patients with end-stage renal disease and concomitant atrial fibrillation.
  • Recommend a direct oral anticoagulant regimen for stroke prevention for the oldest old with atrial fibrillation based on guideline recommendations and primary literature.
  • Recommend a direct oral anticoagulant regimen for stroke prevention for a patient with end-stage renal disease and atrial fibrillation based on guideline recommendations and primary literature.
  • Identify common medication errors involving direct oral anticoagulants for the oldest old or patients with end-stage renal disease.

This activity is approved for Board Certified Ambulatory Care Pharmacist (BCACP) and Board Certified Geriatric Pharmacist (BCGP) recertification credit. 

Infiltrating the Kidneys: Non-Dialysis CKD in Primary Care
ACPE Number: 0217-9999-21-155-H01-P

At the conclusion of this application-based educational activity, participants should be able to do the following:

  • Assess a medication regimen in a patient with complex comorbidities to select appropriate recommendations for renal adjustment.
  • Design a treatment plan for cardiovascular disease management in a patient with chronic kidney disease.
  • Apply key factors of patient safety and efficacy to consider when determining a treatment plan in a patient with chronic kidney disease and osteoporosis.
  • Incorporate ways a clinical pharmacist can play a role in quality care metrics and chronic kidney disease management in everyday practice.

This activity is approved for Board Certified Ambulatory Care Pharmacist (BCACP) and Board Certified Geriatric Pharmacist (BCGP) recertification credit.

Faculty bios

Amie Taggart Blaszczyk, Pharm.D., BCGP, BCPS, FASCP
Professor & Division Head – Geriatrics
Texas Tech University HSC School of Pharmacy
Dallas, Texas 

Dana Carroll, Pharm.D., BCGP, BCPS, CDES*
Clinical Professor
Auburn University Harrison School of Pharmacy
University of Alabama Family Medicine 

Zachary R. Noel, Pharm.D., BCCP, BCPS
Assistant Professor, Department of Pharmacy Practice and Science
University of Maryland School of Pharmacy
Baltimore, Maryland 

Maria Pruchnicki, Pharm.D., FCCP, BCPS, BCACP, CLS
Associate Professor - Clinical
The Ohio State University
Columbus, Ohio 

Maria Shin, Pharm.D., BCGP, BCPS*
Clinical Pharmacy Specialist in Internal Medicine
Robley Rex Louisville Veterans Affairs Medical Center 

Tiffany Shin, Pharm.D., BCACP
Clinical Assistant Professor
University of Kansas
Wichita, Kansas 

Barbara J. Zarowitz, Pharm.D., BCPS, BCGP, FASCP
Senior Advisor, Peter Lamy Center on Drug Therapy and Aging
Affiliate Professor, University of Maryland School of Pharmacy
Baltimore, Maryland

*Content Matter Experts

Holly L. Byrnes, Pharm D., BCPS
Dana Carroll, Pharm.D., BCPS, CDE, BCGP
Susan R. Dombrowski, M.S., R.Ph.
Michelle Hilaire  Pharm.D., BCACP, BCPS, CDE, FCCP
Kristi Hofer, Pharm.D.
Nicholas Leon, Pharm.D., BCPS, BCACP, FCPP
Maria Shin, Pharm.D., BCGP, BCPS

Emily Agnew, Pharm.D., BCPS, BCGP
Michael Andrews, Pharm.D., BCPS, BCACP
Ramadas Balasubramanian, Pharm.D., Ph.D., BCGP, BCACP, FASCP
Carol Botelho, Pharm.D., BCACP, BCGP
James Bottoms, BCGP, CPH
Tina Caliendo, Pharm.D., BCGP, BCACP
Rachel Campbell, Pharm.D., BCPS, BCGP
Christine Chou, Pharm.D., BCPS, BCGP
Emily Christenberry, Pharm.D., BCPS, BCGP
Ariane Conrad, Pharm.D., BCACP, CDCES, FISMP
Stacey Dean, Pharm.D., MSHA
Andrea Donaldson, Pharm.D., BCPS, BCGP
Valerie Emming-Eschbacher, Pharm.D., BCACP
Marty Eng, Pharm.D., BCGP, BCPP
Barbara Fiano, BCGP
Jennifer Fix, B.S., Pharm.D., MBA
Kevin Fuschetto, Pharm.D., BCACP, BC-ADM
Megan Grischeau, Pharm.D., BCACP
Mark Hall, Pharm.D., BCACP
Rhenda Harris , Pharm.D., MBA, BCACP
Christine Ho, Pharm.D., BCPS, BCGP
Debrina Johnson, Pharm.D., BCGP, BCACP
Heather Johnson, Pharm.D., BCPS, BCGP
Rebecca Khaimova, Pharm.D., BCACP
Karen Kier, Ph.D., MSc, BCPS, BCACP
Sonya Kousoum, Pharm.D., BCPS, BCGP
Nancy Laux, Pharm.D., BCPS, BCGP
Brian Leonard, Pharm.D., BCACP, BCGP
Jennifer Lis, Pharm.D., BCACP
Kristine Lopez, Pharm.D., BCGP
Matthew Maddox, Pharm.D., BCACP, BCGP, CPH
Maria McErleane, Pharm.D., BCPS, BCGP
Kristen Miezianko, Pharm.D.
Tera Moore, Pharm.D., BCACP
Hilda Ng , MSc (Clinical Pharmacy), BCGP
Alyssa Norwood, BSPharm, Pharm.D., RPh, BCGP
Zoon Park, Pharm.D., BCGP, BCPS
Sabrina Phillips, Pharm.D., BCACP, BCGP
Stephanie Planisek, Pharm.D., M.S., BCGP, BCMTMS
Melanie Proffitt, Pharm.D., BCACP, MHA
Muhammad Qudoos, Pharm.D., BCGP
Jennifer Quellhorst, Pharm.D., BCPS, BCGP
Jocelyn Reynoso, Pharm.D., BCPS, BCGP
Krystal Riccio, Pharm.D., BCACP, CDCES
Polly Robinson, Pharm.D., BCGP, BCACP, FASCP
Lindsay Sampson, Pharm.D., BCPS, BCGP
Kathryn Sena, Pharm.D., BCGP, PhC
Garcia Simon-Clarke, M.S., Pharm.D, BCNP, BCGP, BCPS
Harleen Singh, Pharm.D., BCPS, BCACP
Teresa Sterling, Pharm.D.
Melissa Tiedeman, Pharm.D., BCGP
Jeffrey Tingen, Pharm.D., MBA, BCPS, BCACP, CDCES
Nicholas Townsend, Pharm.D., BCACP
Mary Jo Trout, Pharm.D., BCPS, BCGP
Agnes Vitarini, Pharm.D.
Michele Walker, Pharm.D., BCGP
Emily Walsh, Pharm.D., BCACP
Alana Whittaker, Pharm.D., BCPS, BCGP
Christine Wu, Pharm.D., BCPS, BCGP
Jessica Yang, Pharm.D., BCACP, BCGP

In accordance with the Accreditation Council for Continuing Medical Education’s Standards for Commercial Support and the Accreditation Council for Pharmacy Education’s Standards for Commercial Support, ASHP requires that all individuals involved in the development of activity content disclose their relevant financial relationships. A person has a relevant financial relationship if the individual of his or her spouse/partner has a financial relationship (e.g. employee, consultant, research grant recipient, speakers bureau, or stockholder) in any amount occurring the in the last 12 months with a commercial interest whose products or series may be discussed in the educational activity content over which the individual has control. The existence of these relationships is provided for the information of participants and should not be assumed to have an adverse impact on the content. 

All faculty and planners for ASHP and ACCP education activities are qualified and selected by ASHP and ACCP and required to disclose any relevant financial relationships with commercial interests. ASHP and ACCP identifies and resolves conflicts of interest prior to an individual’s participation in development of content for an educational activity. Anyone who refuses to disclose relevant financial relationships must be disqualified from any involvement with a continuing pharmacy education activity. 

No one in control of the content of this activity has a relevant financial relationship (RFR) with an ineligible company.

Activities which can be completed in any order. Each activity consists of audio, video, and/or PDFs and evaluations.  Learners must review all content and complete the evaluations to receive continuing pharmacy education credit for each activity. 

Follow the prompts to claim, view, or print the statement of credit within 60 days after completing the activity. 

These activities were developed by ASHP and ACCP.